Bide Pharmatech Statistics

Total Valuation

Bide Pharmatech has a market cap or net worth of CNY 3.84 billion. The enterprise value is 3.53 billion.

Market Cap	3.84B
Enterprise Value	3.53B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Bide Pharmatech has 87.68 million shares outstanding. The number of shares has decreased by -1.62% in one year.

Current Share Class	87.68M
Shares Outstanding	87.68M
Shares Change (YoY)	-1.62%
Shares Change (QoQ)	+2.33%
Owned by Insiders (%)	48.78%
Owned by Institutions (%)	20.59%
Float	26.43M

Valuation Ratios

The trailing PE ratio is 31.95 and the forward PE ratio is 27.37.

PE Ratio	31.95
Forward PE	27.37
PS Ratio	3.38
PB Ratio	1.89
P/TBV Ratio	1.89
P/FCF Ratio	126.77
P/OCF Ratio	32.75
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.24, with an EV/FCF ratio of 116.57.

EV / Earnings	28.93
EV / Sales	3.11
EV / EBITDA	22.24
EV / EBIT	27.17
EV / FCF	116.57

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.15.

Current Ratio	2.88
Quick Ratio	1.48
Debt / Equity	0.15
Debt / EBITDA	1.89
Debt / FCF	9.91
Interest Coverage	27.62

Financial Efficiency

Return on equity (ROE) is 5.98% and return on invested capital (ROIC) is 3.64%.

Return on Equity (ROE)	5.98%
Return on Assets (ROA)	3.22%
Return on Invested Capital (ROIC)	3.64%
Return on Capital Employed (ROCE)	6.26%
Revenue Per Employee	1.54M
Profits Per Employee	165,372
Employee Count	738
Asset Turnover	0.45
Inventory Turnover	0.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.63% in the last 52 weeks. The beta is 0.52, so Bide Pharmatech's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	+33.63%
50-Day Moving Average	43.92
200-Day Moving Average	42.35
Relative Strength Index (RSI)	55.48
Average Volume (20 Days)	1,208,698

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bide Pharmatech had revenue of CNY 1.14 billion and earned 122.04 million in profits. Earnings per share was 1.37.

Revenue	1.14B
Gross Profit	450.91M
Operating Income	129.95M
Pretax Income	160.06M
Net Income	122.04M
EBITDA	141.16M
EBIT	129.95M
Earnings Per Share (EPS)	1.37

Full Income Statement

Balance Sheet

The company has 609.22 million in cash and 300.26 million in debt, giving a net cash position of 308.96 million or 3.52 per share.

Cash & Cash Equivalents	609.22M
Total Debt	300.26M
Net Cash	308.96M
Net Cash Per Share	3.52
Equity (Book Value)	2.03B
Book Value Per Share	23.19
Working Capital	1.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 117.24 million and capital expenditures -86.96 million, giving a free cash flow of 30.28 million.

Operating Cash Flow	117.24M
Capital Expenditures	-86.96M
Free Cash Flow	30.28M
FCF Per Share	0.35

Full Cash Flow Statement

Margins

Gross margin is 39.70%, with operating and profit margins of 11.44% and 10.75%.

Gross Margin	39.70%
Operating Margin	11.44%
Pretax Margin	14.09%
Profit Margin	10.75%
EBITDA Margin	12.43%
EBIT Margin	11.44%
FCF Margin	2.67%

Dividends & Yields

This stock pays an annual dividend of 0.90, which amounts to a dividend yield of 2.06%.

Dividend Per Share	0.90
Dividend Yield	2.06%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	66.83%
Buyback Yield	1.62%
Shareholder Yield	3.68%
Earnings Yield	3.18%
FCF Yield	0.79%

Dividend Details

Stock Splits

The last stock split was on May 25, 2023. It was a forward split with a ratio of 1.4.

Last Split Date	May 25, 2023
Split Type	Forward
Split Ratio	1.4

Scores

Bide Pharmatech has an Altman Z-Score of 4.49.

Altman Z-Score	4.49
Piotroski F-Score	n/a